BUN and/or Creatinine Increased: Intrarenal Cause
Congenital kidney anomalies
Diseases of the kidney associated with a cystic mass
Diseases of the kidney associated with a solid mass
Diseases without a mass primarily manifested as glomerular defects
Diseases without a mass in which there is primarily tubular or interstitial (tubulointerstitial) disease
Suggested Additional Lab Testing
For diseases associated with no mass that are glomerular or tubular, urinalysis is informative.
Glomerular disease is suggested by a high amount of urinary protein (including albumin) and red blood cell (RBC) casts with or without loose RBCs.
Tubular disease is suggested by a moderate degree of urinary protein that is primarily not albumin or other relatively high-molecular-weight proteins.
Granular or white blood cell (WBC) casts or loose WBCs in the urine are often associated with infection.
Because tubular dysfunction can be caused by infections and exposure to drugs, tests for infectious diseases and drug levels can be important.
Renal stones of different composition and multiple myeloma may produce tubular disease.
Tests for renal stones and multiple myeloma involve urinalysis and blood testing.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Do Oral Contraceptives Actually Increase Breast Cancer Risk?
- Pancreatitis and the Risk of Cancer
- FDA Approves Olaparib for BRCA-Positive Breast Cancer
- Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery Prolongs OS in Gastric Cancer
- RAMIE May Improve Post-operative Outcomes Among Patients With Esophageal Cancer
- Pembrolizumab May Be Effective for Previously Treated Hepatocellular Carcinoma
- Cabozantinib May Improve Survival Outcomes in Relapsed Hepatocellular Carcinoma
- PEGPH20 Plus mFOLFIRINOX Worsens OS Among Patients With Pancreatic Cancer
- Gemcitabine Plus S-1 May Be Non-inferior to Standard Therapy for Biliary Tract Cancer
- Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances